Bli medlem
Bli medlem

Du är här


RaySearch Laboratories: Resolutions at the Annual General Meeting 2016

At the Annual General Meeting of RaySearch Laboratories AB (publ) held
on May 17, 2016, the following resolutions were adopted.

It was resolved that a dividend for the fiscal year 2015 amounting to
SEK 0.25 per share be paid out to the shareholders. The remaining
accumulated profit, amounting to SEK 99,961,554.74, was brought
forward and balanced in the new accounts.

The Annual General Meeting adopted the balance sheets and income
statements and discharged the members of the Board and the CEO from
personal liability.

It was resolved to adopt the guidelines for remuneration to senior
executives proposed by the Board, to apply until the close of the
Annual General Meeting 2017.

It was resolved that remuneration to Board members who do not receive
a salary from any Group company, shall amount to a total of SEK
840,000 for the period extending to the close of the next Annual
General Meeting, of which SEK 480,000 will be paid to the Chairman
and SEK 180,000 to each of the Board members elected by the Annual
General Meeting, who do not receive a salary from any Group company.

It was resolved that the Auditor's fees be paid in accordance with
current approved invoicing.

It was resolved to re-elect Carl Filip Bergendal, Erik Hedlund, Johan
Löf and Hans Wigzell as Board members of the company and to re-elect
Erik Hedlund as Chairman of the Board.

It was resolved to re-elect the auditing firm Ernst & Young as
Auditors, with the authorized public accountant Per Hedström as
auditor in charge.

It was resolved to authorize the Board to resolve on new issues of
Series B shares and/or issues of convertible debt instruments, on one
or several occasions up until the Annual General Meeting of 2017, in
accordance with the proposal by the Board.

About RaySearch
RaySearch Laboratories AB (publ) is a medical technology company that
develops advanced software solutions for improved radiation therapy
of cancer. RaySearch markets the RayStation® treatment planning
system to clinics all over the world. In addition, RaySearch's
products are distributed through licensing agreements with leading
medical technology companies. RaySearch's software is used by over
2,600 clinics in more than 65 countries. RaySearch was founded in
2000 as a spin-off from the Karolinska Institute in Stockholm and the
company is listed in the Mid Cap segment on Nasdaq Stockholm.

For more information about RaySearch, visit

For further information, please contact:
Johan Löf, President and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0)8-510 530 00


Författare WKR

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.